Identification of needs in biomarker research

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 5, 1996, Pages 895-900

  Ward Jr , Jonathan B ^a   Henderson, Rogene E ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Inhalation Toxicology Research Institute   (United States)

Author keywords

Biomarkers; Disease risk; Exposure; Medical ethics; Susceptibility

Indexed keywords

BIOLOGICAL MARKER;

CONFERENCE PAPER; DISEASE PREDISPOSITION; HUMAN; MEDICAL ETHICS; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RESEARCH; RISK ASSESSMENT;

EID: 0029832847     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s5895     Document Type: Conference Paper

References (22)

1. National Research Council. Biological markers in environmental health research. Environ Health Perspect 74:3-9 (1987).
2. Ward JB Jr, Ammenheuser MM, Bechtold WE, Whorton EB Jr, Legator MS. hprt Mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ Health Perspect 102:79-85 (1994).
3. Silbergeld, EK. Neurochemical approaches to developing biochemical markers of neurotoxicity: review of current status and evaluation of future prospects. Environ Res 63:274-286 (1993).
4. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prevention 4:253-260 (1995).
5. Athas WF, Hedayati MA, Matanoski GM, Farmer ER, Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 51:5786-5793 (1991).
6. Albertini RJ. Somatic mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutat Res 150:411-422 (1985).
7. Langlois RG, Bigbee WL, Jensen RH. Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Hum Genet 74:353-362 (1986).
8. Sobels FH. Approaches to assessing genetic risks from exposure to chemicals. Environ Health Perspect 101(3):327-332 (1993).
9. Randerath K, Li D, Moorthy B, Randerath E. I-compounds - endogenous DNA markers of nutritional status, aging, tumor progression, and carcinogenesis. IARC Scientific Publications 124:157-165 (1993).
10. Ammenheuser MM, Ward JB Jr, Whorton EB Jr, Killian JM, Legator MS. Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. Mutat Res 204:509-520 (1988).
11. O'Neill JP, Sullivan LM, Booker JK, Pomelos BS, Falta MT, Greene CJ, Albertini RJ. Longitudinal study of the in vivo hprt mutant frequency in human T-lymphocytes as determined by a cell cloning assay. Environ Molec Mutagen 13:289-293 (1989).
12. Ammenheuser MM, Berenson AB, Stiglich NJ, Whorton EB Jr., Ward JB Jr. Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns. Mutat Res 304:285-294 (1994).
13. Sorsa M, Wilborn J, Vainio H. Human cytogenetic damage as a predictor of cancer risk. In: Mechanisms of Carcinogenesis in Risk Identification (Vainio H, Magee PN, McGregor DB, McMichael AJ, eds). Lyon:International Agency for Research on Cancer, 1992;543-554.
14. Kaldor JM, Day NE, Petterson F, Clarke A, Pederson D, Mehnert W, Bell J, Host H, Prior P, Karjalainen S, Neal F, Koch M, Band P, Choi W, Pompe K, Arslan A, Zaren B, Belch AR, Storm H, Kittelmann B, Fraser P, Stovall M. Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322:1-6 (1990).
15. Albertini RJ. Why use somatic mutations for human biomonitoring? Environ Molec Mutagen 23(S24):18-22 (1994).
16. Calleman CJ, Wu Y, He F, Tian G, Bergmark E, Zhang S, Deng H, Wang Y, Crofton KM, Fennell T, Costa LG. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol 126:361-371 (1994).
17. Major J, Matyas GJ, Tompa A. Genotoxicological investigation of hospital nurses occupationally exposed to ethylene-oxide, I: Chromosome aberrations, sister chromatid exchanges, cell cycle kinetics and UV-induced DNA synthesis in peripheral blood lymphocytes. Environ Molec Mutagen 27:84-92 (1996)
18. Galloway SM, Berry PK, Nichols WW, Wolman WR, Soper KA, Stolley PD, Archer P. Chromosome aberrations in individuals occupationally exposed to ethylene oxide, and in a large control population. Mutat Res 170:55-57 (1986).
19. Kelsey KT, Wiencke JK, Ward JB Jr., Bechtold W, Fajen J. Sister chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat Res 335:267-273 (1995).
20. Henderson RF. Biological markers in the respiratory tract. In: Concepts in Inhalation Toxicology, 2nd (McClelland RO, Henderson RF, eds). Washington:Taylor and Francis, 1967;441-504.
21. Henderson RF, Bechtold WE, Bond JA, Sun JD. The use of biological markers in toxicology. CRC Crit Rev Toxicol 20:65-82 (1989).
22. Ward JB Jr, Ammenheuser MM, Whorton EB Jr, Bechtold WE, Kelsey, KT, Legator MS. Biological monitoring for mutagenic effects of occupational exposure to butadiene. Toxicology 110:1-7 (1996).